【摘要】：目的探討凝血功能障礙患者行經(jīng)皮肝膿腫穿刺引流術(shù)的安全性。方法回顧性收集從2013年1月到2014年1月間行經(jīng)皮穿刺引流術(shù)的肝膿腫患者。依據(jù)實(shí)驗(yàn)室檢查結(jié)果 (凝血酶原時間國際正�；戎怠�1.5和血小板計數(shù)≤50×109/L),患者分為正常凝血功能和凝血障礙兩組,比較兩組患者術(shù)后并發(fā)癥的發(fā)生率。結(jié)果共85例肝膿腫患者行膿腫穿刺引流術(shù),正常凝血功能患者67例,凝血障礙患者18例。兩組患者術(shù)前、術(shù)后血紅蛋白水平無明顯差異,術(shù)后所有患者均未出現(xiàn)出血并發(fā)癥。結(jié)論對于凝血功能障礙的肝膿腫患者,行經(jīng)皮肝膿腫穿刺引流術(shù)同樣安全可靠。
[Abstract]:Objective to investigate the safety of percutaneous transhepatic abscess puncture and drainage in patients with coagulation dysfunction. Methods the patients with liver abscess underwent percutaneous puncture and drainage from January 2013 to January 2014 were retrospectively collected. According to the results of laboratory examination (the international normalized ratio of prothrombin time 鈮，

本文編號：2211726